Answers are grounded in this paper and cite their sources.
Methodological analysis reveals trial quality flaws exaggerate intervention benefits across clinical meta-analyses, highlighting drivers of discrepancy between trial sizes.
Inadequate generation of the allocation sequence, allocation concealment, and double blinding lead to exaggerated estimates of intervention benefit and may contribute to discrepancies between the results of large randomized trials and small randomized trials in meta-analyses.
No takes yet. Share an insight, caveat, or question.
Kjaergard et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: